John P. Hamill
Overview
John P. Hamill received $908K in total compensation, including $388K in salary, at Aprea Therapeutics in 2023. John Hamill also received an average of $927K at Discovery Laboratories from 2020 to 2022 and an average of $91K at Cellectar Biosciences between 2017 and 2018.
- 2023
- 2022
- 2021
- 2020
- 2018
- 2017
Aprea TherapeuticsChief Financial Officer
Discovery LaboratoriesFormer Senior VP, CFO, Treasurer and Corporate Secretary
Discovery LaboratoriesSenior VP, CFO, and Corporate Secretary
Discovery LaboratoriesSenior VP, Chief Financial Officer and Corporate Secretary
Cellectar BiosciencesFormer Interim Chief Financial Officer
Cellectar BiosciencesInterim Chief Financial Officer
Source: SEC filings on April 25, 2024, June 29, 2023, May 11, 2022, April 30, 2021, April 29, 2019, and April 23, 2018.
Related executives
We found 29 more executives who work or worked at Aprea Therapeutics, Discovery Laboratories, andCellectar Biosciences.
James Caruso
Cellectar Biosciences
Chief Executive Officer
Jarrod Longcor
Cellectar Biosciences
Chief Operating Officer
Chad Kolean
Cellectar Biosciences
Chief Financial Officer
Oren Gilad
Aprea Therapeutics
Chief Executive Officer
Scott Coiante
Aprea Therapeutics
Chief Financial Officer
Christian Schade
Aprea Therapeutics
Chief Executive Officer
Craig Fraser
Discovery Laboratories
Chief Executive Officer
Eyal Attar
Aprea Therapeutics
Chief Medical Officer
News
Aprea Therapeutics CFO John Hamill's 2023 pay jumps 62% to $908K
April 25, 2024
Discovery Laboratories CEO Craig Fraser's 2022 pay falls 50% to $941K
June 29, 2023
Discovery Laboratories CEO Craig Fraser's 2021 pay jumps 144% to $1.9M
May 11, 2022
Discovery Laboratories COO Eric Curtis receives $1.8M in 2020
April 30, 2021
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019